Catalyst Wire Dossier Catalyst Wire Dossier

VEKLURY

remdesivir · Gilead Sciences, Inc.
Drug timelines are a Plus or Pro feature.

28 regulatory and trial events tracked for VEKLURY, covering 2020-05-11 to 2026-07-29. Get the full timeline:

Most recent: FDA Approved: VEKLURY — Supplemental Application (Gilead Sciences, Inc.)

See pricing